BEFAST (Bubble-Enhanced FAST) for the Evaluation of Solid Organ Injury
NCT05025449 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 267
Last updated 2024-10-08
Summary
The Focused Assessment with Sonography for Trauma (FAST) exam is widely used and accepted as part of advanced trauma life support (ATLS) protocol, but its low sensitivity for identifying solid organ injury in the absence of hemoperitoneum is a significant limitation. Contrast-enhanced ultrasound (CEUS) has the potential to significantly enhance the evaluation of the trauma patient with acute intra-abdominal injury through the use of intravascular microbubbles that allow direct visualization of lacerations to solid organs. European studies have demonstrated that ultrasound contrast markedly improves the sensitivity of ultrasound in detecting solid organ injury, when the exam is performed in the radiology suite. The researchers hypothesize that the bubble-enhanced FAST or BEFAST exam will be more sensitive than traditional FAST for identification of solid organ injury in hemodynamically stable blunt abdominal trauma patients when performed by emergency providers.
Conditions
- Abdominal Trauma
Interventions
- DIAGNOSTIC_TEST
-
Focused Assessment with Sonography for Trauma (FAST)
The Focused Assessment with Sonography for Trauma (FAST) exam is widely used and accepted as part of Advanced Trauma Life Support (ATLS) protocol. After consent, a baseline FAST exam will be performed and documented. This FAST will be distinct from the initial ATLS resuscitation FAST in order to avoid any interference in the trauma evaluation. The investigator will use a phased array or curvilinear transducer to record video of their baseline FAST exam.
- DRUG
-
Bubble-Enhanced FAST (BEFAST)
Following the FAST exam and using the same machine, a BEFAST exam will be performed using a low mechanical index setting in contrast-specific imaging mode. A 2.4 mL IV dose of Lumason will be injected into the subject's IV, followed by saline flush. The contrast will be injected once for the right side of the body, and once for the left side of the body looking for disruptions in the normal enhancement pattern and evidence of active bleeding. To examine the right side of the body: the liver will be imaged first in arterial phase, followed by the right kidney, before returning to image the liver in venous phase. To examine the left side of the body: the pancreas will be imaged first, followed by the kidney and the spleen. The investigator will note evidence of solid organ injury, free fluid, or active extravasation on both sides of the body; lacerations will be graded by the American Association for the Surgery of Trauma (AAST) criteria.
Sponsors & Collaborators
-
United States Department of Defense
collaborator FED -
Emory University
lead OTHER
Principal Investigators
-
Laura Oh, MD · Emory University
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-09-30
- Primary Completion
- 2023-09-14
- Completion
- 2023-09-14
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
The Semaglutide Study
NCT06420739 ·Status: ACTIVE_NOT_RECRUITING
-
A Single-center, Feasibility Study to Evaluate the Use and Safety of the Percutaneous Ultrasound Gastrostomy Technique
NCT03575754 ·Status: COMPLETED ·Phase: NA
-
Residual Gastric Content After Holding of Glucagon-like Peptide-1 Receptor Agonists Before Elective Surgery
NCT06500143 ·Status: COMPLETED
-
Fat Reduction Induced by Magnetic Device - Waist Circumference Evaluation
NCT03547934 ·Status: WITHDRAWN ·Phase: NA
-
Evaluation of the Safety and Effectiveness of Stomaphyx for Transoral Incisionless Reduction of the Enlarged Gastric Pouch and Stoma
NCT01025076 ·Status: COMPLETED ·Phase: PHASE2
-
Gastric Ultrasound To Assess Gastric Contents In Patients On Semaglutide Therapy
NCT06292065 ·Status: COMPLETED ·Phase: NA
-
Fat Reduction Induced by Magnetic Device - Ultrasonographic Evaluation
NCT03537716 ·Status: WITHDRAWN ·Phase: NA
-
Ultrasound-induced Adipose Tissue Cavitation and Training in Obesity
NCT04417816 ·Status: TERMINATED ·Phase: NA
-
Identification of Changes in Gastric Volume and Content by Ultrasound Before and After Chewing Gum
NCT02852863 ·Status: COMPLETED ·Phase: NA
-
Changes in Abdominal Tissues Induced by Magnetic Device - CT Evaluation
NCT03545646 ·Status: WITHDRAWN ·Phase: NA
-
Low-Frequency, High-Intensity Ultrasound for Waist Circumference Reduction
NCT04206384 ·Status: COMPLETED ·Phase: NA
-
Investigation of the Evolution of Gastric Emptying by Gastric Ultra Sonography in Patients Treated With GLP-1 Receptor Agonists on a 7 Days Pausing Period.
NCT06388213 ·Status: NOT_YET_RECRUITING
-
Changes in Abdominal Tissues Induced by Magnetic Device - MRI Evaluation
NCT03545633 ·Status: WITHDRAWN ·Phase: NA
-
Effects of Ultrasound Cavitation Focused on Located Adiposity
NCT02539043 ·Status: COMPLETED ·Phase: NA
-
Use of Transcutaneous Electrical Nerve Stimulation Device, Reletex Reliefband, With Current ERAS (Enhanced Recovery After Surgery) Protocol to Further Decrease Postoperative Nausea and Vomiting in the Bariatric Surgical Patient Within the First 24 Hours Postoperatively.
NCT07063979 ·Status: RECRUITING ·Phase: NA
-
Effects of Beginning a GLP1-Agonist Therapy on Residual Gastric Content and Gastric Emptying
NCT06659159 ·Status: NOT_YET_RECRUITING
-
Gastric Emptying Using Two Imaging Methods for Those Who Have Undergone POSE2 Weight Loss Procedure
NCT04502732 ·Status: TERMINATED
-
Outcome of Gastric Fundus and Pylorus Botulinum Toxin A Injection
NCT04948177 ·Status: COMPLETED
-
Bedside Observation by Clinical Ultrasound for Stomach Expansion
NCT07312890 ·Status: RECRUITING ·Phase: NA
-
Screened Health Assessment & Pacer Evaluation
NCT00312611 ·Status: COMPLETED ·Phase: NA
-
Residual Gastric Volume Measured by Ultrasound in Diabetic Surgical Population Versus Non-diabetic Surgical Population.
NCT05435157 ·Status: COMPLETED
-
Cryolipolisis for Abdomen and Flank Fat Reduction
NCT03033004 ·Status: COMPLETED ·Phase: NA
-
Gastric and Autonomic Functions in Patients With Intragastric Balloon
NCT03530410 ·Status: WITHDRAWN
-
Verification of Endotracheal Tube Placement by Ultrasound in the Obese Patient
NCT01227486 ·Status: COMPLETED
-
Endoscopic Suturing of the Gastric Pylorus to Delay Gastric Emptying and Treat Obesity
NCT02191501 ·Status: TERMINATED ·Phase: NA